Top-Rated Dividend StocksTop-Rated Dividend

Merck & Co., Inc. (MRK) Stock Forecast & Price Target

$105.63

-0.60 (-0.56%)

(As of 12/6/2023 ET)

Compare

Today's Range: $105.43
▼
$106.57
50-Day Range: $100.17
▼
$106.23
52-Week Range: $96.36
▼
$119.65

Volume: 9.52 million shs
Average Volume: 7.58 million shs
Market Capitalization: $267.67 billion

P/E Ratio: 58.68
Dividend Yield: 2.76%
Price Target: $125.14

Merck & Co., Inc. Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 21 Analyst Ratings

Analysts' Consensus Price Target

$125.14
18.47% Upside

High Forecast	$135.00
Average Forecast	$125.14
Low Forecast	$115.00

Type	Current Forecast 12/7/22 to 12/7/23	1 Month Ago 11/7/22 to 11/7/23	3 Months Ago 9/8/22 to 9/8/23	1 Year Ago 12/7/21 to 12/7/22
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	16 Buy rating(s)	15 Buy rating(s)	14 Buy rating(s)	12 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$125.14	$125.65	$124.74	$106.00
Predicted Upside	18.47% Upside	16.09% Upside	14.51% Upside	11.74% Upside

Get Merck & Co., Inc. Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter.

MRK Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MRK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Merck & Co., Inc. Stock vs. The Competition

Type	Merck & Co., Inc.	Medical Companies	S&P 500
Consensus Rating Score	2.76	2.67	2.49
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	18.47% Upside	670.39% Upside	2,089.54% Upside
News Sentiment Rating	Positive News	Neutral News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/29/2023	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$135.00	+34.95%
11/9/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$115.00	+10.15%
10/27/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$115.00 ➝ $118.00	+12.19%
10/27/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$132.00	+25.04%
10/20/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$117.00 ➝ $122.00	+21.48%
10/6/2023	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$122.00	+17.21%
Get the Latest News and Ratings for MRK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Merck & Co., Inc. and its competitors with MarketBeat's FREE daily newsletter.
7/14/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$123.00	+15.70%
5/1/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$128.00 ➝ $130.00	+12.58%
4/16/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral
4/13/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$105.00 ➝ $130.00	+14.29%
4/11/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$123.00 ➝ $124.00	+10.11%
4/10/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mara Goldstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	$130.00	+15.44%
3/28/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
3/13/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Equal Weight	$120.00 ➝ $115.00	+6.79%
3/10/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$125.00 ➝ $130.00	+20.82%
3/7/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight	$122.00 ➝ $127.00	+14.14%
3/7/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$125.00 ➝ $126.00	+13.24%
3/6/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$125.00	+16.95%
2/23/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight	$120.00 ➝ $125.00	+13.08%
2/22/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Peer Perform ➝ Outperform	$127.00	+16.44%
2/3/2023	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$120.00 ➝ $122.00	+17.92%
1/4/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$110.00 ➝ $130.00	+16.97%
1/3/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$108.00 ➝ $120.00	+8.16%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:54 AM ET.

MRK Price Target - Frequently Asked Questions

What is Merck & Co., Inc.'s consensus rating and price target?: According to the issued ratings of 21 analysts in the last year, the consensus rating for Merck & Co., Inc. stock is Moderate Buy based on the current 5 hold ratings and 16 buy ratings for MRK. The average twelve-month price prediction for Merck & Co., Inc. is $125.14 with a high price target of $135.00 and a low price target of $115.00. Learn more on MRK's analyst rating history.
Do Wall Street analysts like Merck & Co., Inc. more than its competitors?: Analysts like Merck & Co., Inc. more than other Medical companies. The consensus rating score for Merck & Co., Inc. is 2.76 while the average consensus rating score for medical companies is 2.68. Learn more on how MRK compares to other companies.
Is Merck & Co., Inc. being upgraded by Wall Street analysts?: Over the previous 90 days, Merck & Co., Inc.'s stock had 2 upgrades by analysts.

Does Merck & Co., Inc.'s stock price have much upside?: According to analysts, Merck & Co., Inc.'s stock has a predicted upside of 16.03% based on their 12-month stock forecasts.
What analysts cover Merck & Co., Inc.?: Merck & Co., Inc. has been rated by BMO Capital Markets, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Morgan Stanley, Truist Financial, and UBS Group in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NYSE:MRK) was last updated on 12/7/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial